Insight is the edge everyone wants. But it has to be timely. It has to be grounded. And usually, great insights incorporate wisdom from varied points of view. Advisory Insights brings together decades of expertise - in medicine, in law, in engineering, and in finance. We bring a perspective of the practicing physician and the implications of FDA decisions in the broader medical context and marketplace. We bring a perspective of those who have successfully run a fund specializing in ultra-rapid analysis and event-driven catalyst trading. We bring the process of timely, accurate analysis for acting quickly upon governmental and regulatory triggers. And we bring it to you in time to help inform the critical decisions you need to make.

Our primary focus is to deliver actionable insights and analyses before, during, and after market-impactful FDA Advisory Committee meetings. We do so with the integrated perspective of multiple, objective, and independent experts. We bring you the ABC's - the Analysis, the Background, and the Context - as soon as the relevant inputs become publicly available so that you can have the edge you need in your investing. We are not psychics. We don't read tea leaves. But we do help you to navigate ahead of the others in this complex marketplace.